Sanjay Chanda
Corporate Officer/Principal at AN2 THERAPEUTICS, INC.
Net worth: 56 188 $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Easom | M | 56 | 15 years | |
| Lucy Day | F | 65 | 20 years | |
| Douglas Giordano | M | 61 | 8 years | |
| Joseph Zakrzewski | M | 60 | 7 years | |
| Margaret M. Madden | F | - | 8 years | |
| Stephanie Wong | F | 50 | 3 years | |
| Josh Eizen | M | 46 | 2 years | |
| Gilbert Marks | M | 66 | 4 years | |
| Michael R. K. Alley | M | - | 7 years | |
| Kabeer Aziz | M | 34 | 5 years | |
| Robin Readnour | M | 60 | 5 years | |
| Gerard Pereira | M | - |
Cortene, Inc.
 Cortene, Inc. BiotechnologyHealth Technology Cortene, Inc. develops interventional treatment for myalgic encephalomyelitis. The company is headquartered in Burlingame, CA. | - |
| Melvin Spigelman | M | 75 | 2 years | |
| Patricia Martin | F | 63 | 3 years | |
| Bryan Supran | M | - | 8 years | |
| Paul Eckburg | M | 54 | 5 years | |
| Maggie FitzPatrick | F | 58 | 2 years | |
| Carmen R. Rodriguez | F | 75 | 14 years | |
| Kevin Krause | M | 49 | 3 years | |
| Vincent Hernandez | M | - | 5 years | |
| Carole Nüchterlein | F | 62 |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 8 years |
| Jennifer Huber | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul Berns | M | 57 | 4 years | |
| David Perry | M | 56 | 12 years | |
| Robert Karr | M | 75 |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | - |
| Julie Cherrington | M | 66 |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 3 years |
| Mark Leschly | M | 55 | 14 years | |
| Lucy Shapiro | M | 83 | 16 years | |
| John R. Donovan | M | - |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 1 years |
| Zhi Hong | M | 60 | 2 years | |
| Graeme Bell | M | 57 | 1 years | |
| Keith Leonard | M | 62 | 2 years | |
| Ryan Sullivan | M | 48 | 2 years | |
| William Rieflin | M | 64 | 5 years | |
| Stephen Benkovic | M | - | 9 years | |
| Richard Markham | M | 73 | 7 years | |
| Wendell Wierenga | M | 76 | 2 years | |
| Anders Hove | M | 58 | 11 years | |
| Kurt Jarnagin | M | - | - | |
| Vincent Ippolito | M | 65 | 3 years | |
| Christine E. Gray-Smith | F | - | 2 years | |
| Pankaj Bhargava | M | 54 |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 1 years |
| Erik D. Wiberg | M | - | - | |
| Michael Nazak | M | 66 | - | |
| Geoffrey Parker | M | 59 | 6 years | |
| Lee T. Zane | M | 54 | - | |
| Courtney Barton | F | 41 | 2 years | |
| Howie McKibbon | M | - | 3 years | |
| Annie Yoshiyama | F | 41 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 49 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sanjay Chanda
- Personal Network
